Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Brian Parkin

Showing results (11-20 of 24) with videos related to

Pageof 3
Sort By:
Frontiers in Immunology|December 5, 2022
Heterogeneity of neutrophils and inflammatory responses in patients with COVID-19 and healthy controlsJintao Xu, Bing He, Kyle Carver, et al.
Blood|November 24, 2012
Clonal evolution and devolution after chemotherapy in adult acute myelogenous leukemiaBrian Parkin, Peter Ouillette, Yifeng Li, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 11, 2011
A pathobiological role of the insulin receptor in chronic lymphocytic leukemiaKamlai Saiya-Cork, Roxane Collins, Brian Parkin, et al.
Blood|August 9, 2017
Vorinostat plus tacrolimus/methotrexate to prevent GVHD after myeloablative conditioning, unrelated donor HCTSung Won Choi, Thomas Braun, Israel Henig, et al.
Blood|August 24, 2010
Acquired genomic copy number aberrations and survival in adult acute myelogenous leukemiaBrian Parkin, Harry Erba, Peter Ouillette, et al.
Oncogene|February 16, 2020
Therapeutic targeting of TP53-mutated acute myeloid leukemia by inhibiting HIF-1α with echinomycinYin Wang, Yan Liu, Christopher Bailey, et al.
Blood Advances|October 4, 2021
Type 1 interferon to prevent leukemia relapse after allogeneic transplantationJohn M Magenau, Dan Peltier, Mary Riwes, et al.
Bone Marrow Transplantation|February 28, 2019
Maintenance sorafenib in FLT3-ITD AML following allogeneic HCT favorably impacts relapse and overall survivalGrant Chappell, Marcus Geer, Erin Gatza, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|April 9, 2019
A Phase 2 Study of Pembrolizumab during Lymphodepletion after Autologous Hematopoietic Cell Transplantation for Multiple MyelomaAnita D'Souza, Parameswaran Hari, Marcelo Pasquini, et al.
Blood|November 28, 2014
Activating STAT6 mutations in follicular lymphomaMehmet Yildiz, Hongxiu Li, Denzil Bernard, et al.
Pageof 3

Showing results (11-20 of 24) with videos related to

Sort By:
Pageof 3
Frontiers in Immunology|December 5, 2022
Heterogeneity of neutrophils and inflammatory responses in patients with COVID-19 and healthy controlsJintao Xu, Bing He, Kyle Carver, et al.
Blood|November 24, 2012
Clonal evolution and devolution after chemotherapy in adult acute myelogenous leukemiaBrian Parkin, Peter Ouillette, Yifeng Li, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 11, 2011
A pathobiological role of the insulin receptor in chronic lymphocytic leukemiaKamlai Saiya-Cork, Roxane Collins, Brian Parkin, et al.
Blood|August 9, 2017
Vorinostat plus tacrolimus/methotrexate to prevent GVHD after myeloablative conditioning, unrelated donor HCTSung Won Choi, Thomas Braun, Israel Henig, et al.
Blood|August 24, 2010
Acquired genomic copy number aberrations and survival in adult acute myelogenous leukemiaBrian Parkin, Harry Erba, Peter Ouillette, et al.
Oncogene|February 16, 2020
Therapeutic targeting of TP53-mutated acute myeloid leukemia by inhibiting HIF-1α with echinomycinYin Wang, Yan Liu, Christopher Bailey, et al.
Blood Advances|October 4, 2021
Type 1 interferon to prevent leukemia relapse after allogeneic transplantationJohn M Magenau, Dan Peltier, Mary Riwes, et al.
Bone Marrow Transplantation|February 28, 2019
Maintenance sorafenib in FLT3-ITD AML following allogeneic HCT favorably impacts relapse and overall survivalGrant Chappell, Marcus Geer, Erin Gatza, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|April 9, 2019
A Phase 2 Study of Pembrolizumab during Lymphodepletion after Autologous Hematopoietic Cell Transplantation for Multiple MyelomaAnita D'Souza, Parameswaran Hari, Marcelo Pasquini, et al.
Blood|November 28, 2014
Activating STAT6 mutations in follicular lymphomaMehmet Yildiz, Hongxiu Li, Denzil Bernard, et al.
Pageof 3